Price Regulation for Medicinal Products in Slovenia
The reference price system is applied in a practice in Slovenia with an aim to manage and reduce public expenditures for medicinal products. This paper aims to investigate whether the reference price system has had the effect on real price reductions for medicinal products. We present the reference price regulation system for medicinal products and empirically estimate the effect of price regulation on development of real prices for medicinal products, the economic rationale and efficiency of the system. The main thesis that the nominal and real prices for medicinal products have declined during the price regulation system is revealed by the Laspeyres index and Wilcoxon signed ranks test by confirming the existence of statistically significant differences in prices for medicinal products. Therefore, we adopt the alternative hypothesis that prices for medicinal products have declined during the price regulation system. The reference price regulation system with an efficient use of medicinal products and their efficient supply could have positive effects on management and reduction of public expenditure for medicinal products.
|This chapter was published in: Stefan Bojnec & Romana Kajdiz , , pages 185-192, 2012.|
|This item is provided by International School for Social and Business Studies, Celje, Slovenia in its series Knowledge and Learning: Global Empowerment; Proceedings of the Management, Knowledge and Learning International Conference 2012 with number 185-192.|
|Contact details of provider:|| Web page: http://www.issbs.si|
When requesting a correction, please mention this item's handle: RePEc:isv:mklp12:185-192. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Goran Dakovic)
If references are entirely missing, you can add them using this form.